Udelson JE, Lewis GD, Shah SJ, Zile MR, et al. Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved Am Heart J 2020;222:183-190.
PMID: 32105984